(Reuters) – Drugstore retailer CVS Health Corp (CVS.N) beat analyst estimates for adjusted quarterly profit on Wednesday as it sold more prescription drugs at its stores.
FILE PHOTO A logo of CVS Health is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. REUTERS/Lucas Jackson/File Photo
CVS, which agreed to buy health insurer Aetna (AET.N) in a $69 billion deal in December, said it now expects the deal to close during the third quarter or early in the fourth quarter of 2018.
The Aetna deal is likely to…